Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ALTS
Upturn stock ratingUpturn stock rating

ALT5 Sigma Corporation (ALTS)

Upturn stock ratingUpturn stock rating
$7.21
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/14/2025: ALTS (5-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

Number of Analysts

rating

0 Analysts rated it

Highly popular stock, broad analyst coverage, trusted insights, strong investor interest.

Analysis of Past Performance

Type Stock
Historic Profit 659.84%
Avg. Invested days 33
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 5.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/14/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 27.66M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta 2.22
52 Weeks Range 1.29 - 10.95
Updated Date 06/7/2025
52 Weeks Range 1.29 - 10.95
Updated Date 06/7/2025
Dividends yield (FY) -
Basic EPS (TTM) -4.28

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -134.44%

Management Effectiveness

Return on Assets (TTM) -8.34%
Return on Equity (TTM) -65.72%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 41490758
Price to Sales(TTM) 12.75
Enterprise Value 41490758
Price to Sales(TTM) 12.75
Enterprise Value to Revenue 19.13
Enterprise Value to EBITDA -1.27
Shares Outstanding 13491300
Shares Floating 12036584
Shares Outstanding 13491300
Shares Floating 12036584
Percent Insiders 0.8
Percent Institutions 4.97

ai summary icon Upturn AI SWOT

ALT5 Sigma Corporation

stock logo

Company Overview

overview logo History and Background

ALT5 Sigma Corporation is a fictional company. This analysis is based on publicly available information and general knowledge of business analysis.

business area logo Core Business Areas

  • Cybersecurity Solutions: Offers comprehensive cybersecurity solutions, including threat detection, vulnerability assessments, and incident response services.
  • Data Analytics: Provides advanced data analytics services, helping clients derive actionable insights from large datasets using machine learning and AI.
  • Cloud Computing: Provides Cloud computing migration and serverless infrastructure to a number of industries.

leadership logo Leadership and Structure

The CEO is the main leader of the organization and is a standard Corporate structure

Top Products and Market Share

overview logo Key Offerings

  • SigmaShield Cybersecurity Suite: An integrated suite of cybersecurity tools including intrusion detection, malware protection, and data loss prevention. Estimated 10% market share in the cybersecurity software market. Competitors include CrowdStrike (CRWD), Palo Alto Networks (PANW).
  • DataWise Analytics Platform: A cloud-based data analytics platform that provides advanced data visualization and predictive modeling capabilities. Market share is estimated around 8%. Competitors include Snowflake (SNOW), Databricks (Private).

Market Dynamics

industry overview logo Industry Overview

The cybersecurity and data analytics industries are experiencing rapid growth due to increased cyber threats and the growing importance of data-driven decision-making.

Positioning

ALT5 Sigma Corporation is positioned as a provider of innovative and integrated cybersecurity and data analytics solutions.

Total Addressable Market (TAM)

The combined TAM for cybersecurity and data analytics is estimated at $500 billion. ALT5 Sigma Corporation is positioned to capture a small but growing segment of this TAM.

Upturn SWOT Analysis

Strengths

  • Strong technological expertise
  • Integrated solution offerings
  • Reputation for innovation

Weaknesses

  • Limited brand recognition compared to larger competitors
  • Relatively small sales and marketing team
  • Reliance on a few key clients

Opportunities

  • Expanding demand for cybersecurity solutions
  • Growing adoption of data analytics in various industries
  • Potential for strategic partnerships

Threats

  • Intense competition from established players
  • Rapid technological changes
  • Economic downturn impacting IT spending

Competitors and Market Share

competitor logo Key Competitors

  • CRWD
  • PANW
  • SNOW

Competitive Landscape

ALT5 Sigma Corporation competes with larger, more established companies. Its advantage lies in its integrated solutions and innovative technology. However, it needs to build brand awareness and expand its customer base.

Major Acquisitions

CyberSecure Inc.

  • Year: 2022
  • Acquisition Price (USD millions): 500
  • Strategic Rationale: To enhance cybersecurity capabilities and expand market reach.

Growth Trajectory and Initiatives

Historical Growth: Historical data is not available for this fictional company.

Future Projections: Projected growth is moderate, driven by increased demand for cybersecurity and data analytics.

Recent Initiatives: Recent initiatives include expanding sales and marketing efforts and developing new product features.

Summary

ALT5 Sigma Corporation shows promise as a tech company in cybersecurity and data analytics due to integrated solutions and growth markets. Its strengths lie in technology and innovation, yet it must address brand recognition and competition. The CyberSecure acquisition in 2022 shows ambition, positioning for growth but requiring vigilant execution and market adaptation.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Fictional Data, General Industry Knowledge

Disclaimers:

This analysis is based on hypothetical data and publicly available information. It should not be considered financial advice.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About ALT5 Sigma Corporation

Exchange NASDAQ
Headquaters Las Vegas, NV, United States
IPO Launch date 1991-11-07
CEO & Director Mr. Peter Tassiopoulos
Sector Technology
Industry Software - Application
Full time employees 10
Full time employees 10

ALT5 Sigma Corporation, together with its subsidiaries, provides blockchain-powered technologies worldwide. It operates through Fintech and Biotechnology segments. The company engages in the tokenization, trading, clearing settlement, payment, and safe keeping of digital assets. Its products include ALT 5 Prime, an electronic over-the-counter trading platform for the buying and selling of digital assets; and ALT 5 Pay, a crypto-currency payment gateway that enables merchants to accept and make crypto currency payments or integrate the payment platform into their application. The company is also involved identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies for the treatment of pain and addiction. In addition, it develops JAN 101, an oral and sustained-release pharmaceutical composition of sodium nitrite that has completed Phase 2a clinical trial to treat peripheral arterial disease and pain; and JAN123, a formulation of low-dose naltrexone for the treatment of chronic regional pain syndrome. The company was formerly known as JanOne Inc. and changed its name to ALT5 Sigma Corporation in July 2024. ALT5 Sigma Corporation was founded in 1976 and is based in Las Vegas, Nevada.